Dr. Michael Lee, MD

Dr. Lee practices at Dignity Health - Mercy Hospital Downtown in Bakersfield, California, part of CommonSpirit Health.

Dr. Lee's NPI, 1417161886, was assigned on May 9, 2007. Dr. Lee graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2004. Dr. Lee's Louisiana license number on file is 206767.

Dr. Lee's primary practice is Dignity Health - Mercy Hospital Downtown, at 2215 Truxtun Avenue, Bakersfield, CA 93301 in Kern County. The practice phone is (661) 632-5000.

Dr. Lee's primary practice is Dignity Health - Mercy Hospital Downtown in Bakersfield, California, part of CommonSpirit Health. The medical group on file is US Acute Care Solutions. Dmand AI also links Dr. Lee to 8 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Lee is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Lee's licenses on file in 6 states: Louisiana, California, Guam, Minnesota, Alabama and Oklahoma.

CMS data shows 761 Medicare services from Dr. Lee across 5 procedure codes in 2024, for 551 Medicare patients. Medicare paid $81,592 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 551 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 50, with 59% women.

In 2024, Dr. Lee wrote 271 Medicare Part D claims for 204 patients. 93% of them were for generic drugs. CMS names the drug for 134 of them, across 6 drugs with 11 or more claims each, at $660 in total drug cost. In 2023, CMS named 122 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lee for performance year 2024, reported as part of a group.

Dmand AI links 137 papers to Dr. Lee, published from 2004 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Mice, Transgenic, Alzheimer Disease and Brain. Dr. Lee has published most often in Neuron. Dr. Lee's most frequent co-authors are Antonio Colombo, MD, Usman Baber, MD and George D. Dangas, MD.

Dmand AI links Dr. Lee to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease, Plaque, Atherosclerotic and Coronary Disease.

CMS Open Payments shows 6 general payments to Dr. Lee from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $39.

Dr. Lee graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2004.

Dr. Lee is in network with 2 carriers, including United Healthcare and Elevance. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.